Dr Daniel T Mcmullan, MD in Birmingham, AL - Medicare Pathology

Dr Daniel T Mcmullan, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Birmingham, Alabama. His current practice location is 924 Montclair Rd, Ste 200, Birmingham, Alabama. You can reach out to his office (for appointments etc.) via phone at (205) 591-7999.

Dr Daniel T Mcmullan is licensed to practice in Alabama (license number 15066) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1164428843.

Contact Information

	Dr Daniel T Mcmullan, MD
	924 Montclair Rd, Ste 200, Birmingham, AL 35213-1200
	(205) 591-7999
	(205) 591-5051

Physician's Profile

Full Name	Dr Daniel T Mcmullan
Gender	Male
Speciality	Pathology - Anatomic Pathology & Clinical Pathology
Location	924 Montclair Rd, Birmingham, Alabama
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1164428843
Provider Enumeration Date: 06/27/2005
Last Update Date: 11/09/2009

Medicare PECOS Information:

PECOS PAC ID: 8224024476
Enrollment ID: I20040422001009

Medical Identifiers

Medical identifiers for Dr Daniel T Mcmullan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1164428843	NPI	-	NPPES
AL000007467	Medicaid	AL

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0102X	Pathology - Anatomic Pathology & Clinical Pathology	15066 (Alabama)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Daniel T Mcmullan allows following entities to bill medicare on his behalf.

Entity Name	Urology Centers Of Alabama Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1710962550 PECOS PAC ID: 0941264345 Enrollment ID: O20041116000389

News Archive

Developing a COVID-19 vaccine using inactivated E. coli

A team of researchers inactivated whole-cell E.coli with a reduced genome and utilized this to express coronavirus-specific fusion peptides, demonstrating a potent anamnestic response.

Findings highlight importance of IL-21 in the development of antiviral vaccines

Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

Researchers reveal first three-dimensional molecular map of protein linked to many cancers

Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular 'map' of a protein that has been pinpointed as a driver of many types of cancers.

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

Questions regarding effectiveness, infrastructure and cost effectiveness of low-dose computed tomography (CT) screening of those at high risk for lung cancer have now been answered. Medicare should rapidly provide full national coverage for these exams.

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

ZIOPHARM Oncology, Inc. announced today that Dr. Claire Verschraegen of the University of New Mexico, Albuquerque and first author of the abstract, "A phase II randomized controlled trial of palifosfamide plus doxorubicin vs. doxorubicin in patients with soft tissue sarcoma (PICASSO)," (Abstract #10004) presented in an oral session today updated positive data from PICASSO.

Entity Name	Cunningham Pathology, Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1831195437 PECOS PAC ID: 2668468802 Enrollment ID: O20080218000071

Developing a COVID-19 vaccine using inactivated E. coli

A team of researchers inactivated whole-cell E.coli with a reduced genome and utilized this to express coronavirus-specific fusion peptides, demonstrating a potent anamnestic response.

Findings highlight importance of IL-21 in the development of antiviral vaccines

Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

Researchers reveal first three-dimensional molecular map of protein linked to many cancers

Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular 'map' of a protein that has been pinpointed as a driver of many types of cancers.

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Daniel T Mcmullan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Daniel T Mcmullan, MD 924 Montclair Rd, Ste 200, Birmingham, AL 35213-1200 Ph: (205) 591-7999	Dr Daniel T Mcmullan, MD 924 Montclair Rd, Ste 200, Birmingham, AL 35213-1200 Ph: (205) 591-7999

News Archive

Developing a COVID-19 vaccine using inactivated E. coli

A team of researchers inactivated whole-cell E.coli with a reduced genome and utilized this to express coronavirus-specific fusion peptides, demonstrating a potent anamnestic response.

Findings highlight importance of IL-21 in the development of antiviral vaccines

Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

Researchers reveal first three-dimensional molecular map of protein linked to many cancers

Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular 'map' of a protein that has been pinpointed as a driver of many types of cancers.

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

Pathology Doctors in Birmingham, AL

Dr. Kyle Charles Mills, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2800 Fax: 205-949-2801
Leona Council, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5038
Dr. Alexander Wong, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3550 Independence Dr, Birmingham, AL 35209 Phone: 205-949-2806 Fax: 205-949-2875
Dr. David Ullman, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 625 19th St S, Birmingham, AL 35233 Phone: 205-934-4977
Dr. Jonathan G Phillips, MD Pathology Medicare: Medicare Enrolled Practice Location: 924 Montclair Rd, Ste 200, Birmingham, AL 35213 Phone: 205-591-7999 Fax: 205-591-5051
Thomas S Winokur, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 619 19th Street South, Birmingham, AL 35233 Phone: 205-934-6600
Isam Eltoum, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999

Dr Daniel T Mcmullan, MD - Medicare Pathology in Birmingham, AL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Developing a COVID-19 vaccine using inactivated E. coli

Findings highlight importance of IL-21 in the development of antiviral vaccines

Researchers reveal first three-dimensional molecular map of protein linked to many cancers

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

Developing a COVID-19 vaccine using inactivated E. coli

Findings highlight importance of IL-21 in the development of antiviral vaccines

Researchers reveal first three-dimensional molecular map of protein linked to many cancers

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Developing a COVID-19 vaccine using inactivated E. coli

Findings highlight importance of IL-21 in the development of antiviral vaccines

Researchers reveal first three-dimensional molecular map of protein linked to many cancers

USPSTF lung cancer screening recommendations in high-risk Medicare beneficiaries is cost effective

ZIOPHARM presents positive data from PICASSO Phase II trial for soft tissue sarcoma at 46th ASCO

Pathology Doctors in Birmingham, AL